Illumina’s accelerator has an impressive 93 percent follow-on funding rate — here’re its latest picks

Since its launch in 1998 Illumina and its genetic analysis toolkits and services have become an essential component of the new biological manufacturing and therapeutic development industries which hav

5 Years ago

Science years whose while wellsim wing will where work